University of California San Francisco
Give to UCSF
Hear 26 teams of physicians, scientists and students present what they learned about moving their ideas from the lab or clinic to the marketplace in the nation’s first course on applying the Lean Launchpad model of entrepreneurship to the bioscience, medical devices and digital health sectors.
Today, with a host of tools garnered from precision medicine, patients can benefit from precise and effective therapies for some of the world's most daunting illnesses. <em>UCSF Magazine</em> explores the promise of precision medicine.
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.
A UCSF opthamologist and bioengineer are collaborating to develop a tiny, flexible, implantable film that's able to deliver conventional medicines and also complex antibody-based drugs to treat eye diseases.
A team of UCSF researchers developing cell-based therapies for acute respiratory distress syndrome benefited from advisors who helped identify gaps in their development plan.
Teams of scientists at UCSF are collaborating to build upon existing imaging techniques and find new ways to monitor diseases using creative applications of emerging technologies.
Ruben Rathnasingham, PhD, associate director of Early Translational Research at UCSF's Clinical and Translational Science Institute, is leading the team responsible for LaunchPad. In this Q&A, he discusses the project and how it can benefit researchers.
A consortium of the five University of California medical campuses, including UCSF, has been awarded a $12 million grant and designated by the National Institutes of Health as one of three Centers for Accelerated Innovations by the National Heart, Lung and Blood Institute.
<p>An innovative project to develop a potential therapy to treat a wide range of cancers has won a major UC San Francisco award that aims to drive promising early-stage research through the complex process of translating ideas into patient benefit.</p>
<p>Although it’s proven that contraception prevents pregnancy, it’s also clear that many women who don’t want to get pregnant don’t use or don’t have access to contraception. Christine Dehlendorf, MD, MAS, a family physician based at San Francisco General Hospital and Trauma Center, used implementation science to help women navigate this issue.</p>
<p>Ralph Gonzales, MD, a professor in the UCSF School of Medicine, and director of the Implementation Science program at UCSF’s Clinical and Translational Science Institute, answers frequenlty asked questions about the growing field of implementation science.</p>
<p>A patient in rural Uganda is diagnosed with tuberculosis but never begins treatment. In Vietnam, someone with infectious TB might never be diagnosed because the health center is too far away. Adithya Cattamanchi, MD, is working to address challenges in Uganda and Vietnam by applying techniques of <a href="http://accelerate.ucsf.edu/training/ids">implementation </a><a href="http://accelerate.ucsf.edu/training/ids">science</a>.</p>
<p>Two years after launching as a pilot effort, an innovative graduate curriculum in translational medicine jointly offered by <abbr title="University of California, San Francisco">UCSF</abbr> and <abbr title="University of California">UC</abbr> Berkeley has received final approval from University of California President Mark Yudof as a master’s degree program.</p>